Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

被引：0
|
作者：
Giles W Robinson
Brent A Orr
Amar Gajjar
机构：
[1] St Jude Children’s Research Hospital,Division of Neuro
[2] St Jude Children’s Research Hospital,Oncology, Department of Oncology
来源：
BMC Cancer | / 14卷
关键词：
High-grade glioma; Glioblastoma multiforme; mutations; Pediatric brain tumor; inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
    Robinson, Giles W.
    Orr, Brent A.
    Gajjar, Amar
    BMC CANCER, 2014, 14
  • [2] Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma
    Tina Dasgupta
    Aleksandra K. Olow
    Xiaodong Yang
    Rintaro Hashizume
    Theodore P. Nicolaides
    Maxwell Tom
    Yasuyuki Aoki
    Mitchel S. Berger
    William A. Weiss
    Lukas J. A. Stalpers
    Michael Prados
    C. David James
    Sabine Mueller
    Daphne A. Haas-Kogan
    Journal of Neuro-Oncology, 2016, 126 : 385 - 393
  • [3] Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma
    Tina Dasgupta
    Aleksandra K. Olow
    Xiaodong Yang
    Rintaro Hashizume
    Theodore P. Nicolaides
    Maxwell Tom
    Yasuyuki Aoki
    Mitchel S. Berger
    William A. Weiss
    Lukas J. A. Stalpers
    Michael Prados
    C. David James
    Sabine Mueller
    Daphne A. Haas-Kogan
    Journal of Neuro-Oncology, 2016, 126 : 395 - 395
  • [4] Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
    Yu Kanemaru
    Manabu Natsumeda
    Masayasu Okada
    Rie Saito
    Daiki Kobayashi
    Takeyoshi Eda
    Jun Watanabe
    Shoji Saito
    Yoshihiro Tsukamoto
    Makoto Oishi
    Hirotake Saito
    Masayuki Nagahashi
    Takahiro Sasaki
    Rintaro Hashizume
    Hidefumi Aoyama
    Toshifumi Wakai
    Akiyoshi Kakita
    Yukihiko Fujii
    Acta Neuropathologica Communications, 7
  • [5] Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
    Kanemaru, Yu
    Natsumeda, Manabu
    Okada, Masayasu
    Saito, Rie
    Kobayashi, Daiki
    Eda, Takeyoshi
    Watanabe, Jun
    Saito, Shoji
    Tsukamoto, Yoshihiro
    Oishi, Makoto
    Saito, Hirotake
    Nagahashi, Masayuki
    Sasaki, Takahiro
    Hashizume, Rintaro
    Aoyama, Hidefumi
    Wakai, Toshifumi
    Kakita, Akiyoshi
    Fujii, Yukihiko
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (1) : 119
  • [6] Clinical research progress on BRAF V600E-mutant advanced colorectal cancer
    Zeng, Chuanxiu
    Wang, Mengchao
    Xie, Shuqi
    Wang, Na
    Wang, Zhen
    Yi, Dan
    Kong, Fanming
    Chen, Liwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (17) : 16111 - 16121
  • [7] BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
    Munjapara, Vasu
    Heumann, Thatcher
    Schreck, Karisa C.
    Gross, John M.
    Perez-Heydrich, Carlos
    Gujar, Sachin K.
    Eberhart, Charles G.
    Holdhoff, Matthias
    CASE REPORTS IN ONCOLOGY, 2022, 15 (03): : 909 - 917
  • [8] Clinical research progress on BRAF V600E-mutant advanced colorectal cancer
    Chuanxiu Zeng
    Mengchao Wang
    Shuqi Xie
    Na Wang
    Zhen Wang
    Dan Yi
    Fanming Kong
    Liwei Chen
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16111 - 16121
  • [9] BRAF V600E-mutant colorectal cancers: Where are we?
    Lievre, Astrid
    de la Fouchardiere, Christelle
    Samalin, Emmanuelle
    Benoist, Stephane
    Phelip, Jean-Marc
    Andre, Thierry
    Lledo, Gerard
    BULLETIN DU CANCER, 2020, 107 (09) : 881 - 895
  • [10] Overcoming resistance in a BRAF V600E-mutant adenocarcinoma of the lung
    Schmid, T.
    Buess, M.
    CURRENT ONCOLOGY, 2018, 25 (03) : E217 - E219
12345